Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for biote Corp. (BTMD : NSDQ)

• Company Description    BioTE Holdings, LLC is a medical practice-building business within the hormone optimization space. BioTE Holdings, LLC, formerly known as Haymaker Acquisition Corp. III, is based in NEW YORK. Number of Employees: 217

• Price / Volume Information    Yesterday's Closing Price: $4.21 Daily Weekly Monthly 20 Day Moving Average: 114,281 shares Shares Outstanding: 54.71 (millions) Market Capitalization: $230.33 (millions) Beta: 1.21 52 Week High: $8.44 52 Week Low: $3.04 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 6.58% 2.59% 12 Week 27.58% 7.31% Year To Date -31.88% -36.20%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1875 W. WALNUT HILL LN SUITE 100 - IRVING,TX 75038 USA ph: 844-604-1246 fax: 888-496-0394 ir@biote.com https://biote.com

• General Corporate Information    Officers Bret Christensen - Chief Executive Officer and Director Marc D. Beer - Executive Chairman and Director Robert C. Peterson - Chief Financial Officer Dana Jacoby - Director Mark Cone - Director Peer Information biote Corp. (BJCT) biote Corp. (CADMQ) biote Corp. (APNO) biote Corp. (UPDC) biote Corp. (IMTIQ) biote Corp. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 090683103 SIC: 2833 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/14/25 Share - Related Items Shares Outstanding: 54.71 Most Recent Split Date: (:1) Beta: 1.21 Market Capitalization: $230.33 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.10 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.32 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/14/25

• Fundamental Ratios P/E Current FY Estimate: 13.16 Trailing 12 Months: 6.48 PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: 5.50 Price / Sales: 1.16 EPS Growth vs. Year Ago Period: -65.22% vs. Previous Quarter: -20.00% Sales Growth vs. Year Ago Period: 4.67% vs. Previous Quarter: -1.69% ROE 06/30/25 - - 03/31/25 - -19.44 12/31/24 - -25.91 ROA 06/30/25 - - 03/31/25 - 20.12 12/31/24 - 22.59 Current Ratio 06/30/25 - - 03/31/25 - 1.42 12/31/24 - 1.32 Quick Ratio 06/30/25 - - 03/31/25 - 1.14 12/31/24 - 1.03 Operating Margin 06/30/25 - - 03/31/25 - 11.10 12/31/24 - 13.65 Net Margin 06/30/25 - - 03/31/25 - 10.93 12/31/24 - 3.05 Pre-Tax Margin 06/30/25 - - 03/31/25 - 10.93 12/31/24 - 0.52 Book Value 06/30/25 - - 03/31/25 - -1.55 12/31/24 - -2.78 Inventory Turnover 06/30/25 - - 03/31/25 - 3.60 12/31/24 - 3.36 Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - -

Powered by Zacks Investment Research ©